Literature DB >> 22549389

Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: progress, challenges and reflections.

Xiao-feng Zhai1, Chang-quan Ling.   

Abstract

Malignant tumors are one of the leading causes of death in the world. Considerable progresses have been made on the treatment of tumors in recent decades, especially in the prevention, early diagnosis and the model changing of therapeutics. But we are still facing tough challenges, including the increasing treatment burden and limited improvement of efficacy. In China, Chinese medicine (CM) provides a powerful arsenal to fight against tumors. CM can be well applied to the onset and progression of tumors in China, bearing the characteristics of multi-target, multi-phase and multi-effect. But there are also many problems demanding urgent attention in the use of CM. Some most debated problems in this field were summarized. We should upgrade our concepts in using CM, find its position scientifically, and establish evidence of its effect by high quality clinical research.

Entities:  

Mesh:

Year:  2012        PMID: 22549389     DOI: 10.1007/s11655-012-1082-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  13 in total

1.  [Guidelines for evidence-based Chinese medicine clinical pathway report].

Authors:  Si Cheng Wang; Jian-Ping Liu; Hui Li; He Yu
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2010-09

Review 2.  Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.

Authors:  Marja J Verhoef; Lynda G Balneaves; Heather S Boon; Annette Vroegindewey
Journal:  Integr Cancer Ther       Date:  2005-12       Impact factor: 3.279

3.  How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking?

Authors:  Michael J Thun; Ahmedin Jemal
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care.

Authors:  Digant Gupta; Christopher G Lis; Timothy C Birdsall; James F Grutsch
Journal:  Support Care Cancer       Date:  2005-04-23       Impact factor: 3.603

6.  Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis.

Authors:  Ignacio Correa-Velez; Alexandra Clavarino; Heather Eastwood
Journal:  J Palliat Med       Date:  2005-10       Impact factor: 2.947

Review 7.  Overview of gefitinib in non-small cell lung cancer: an Asian perspective.

Authors:  Haiyi Jiang
Journal:  Jpn J Clin Oncol       Date:  2008-12-16       Impact factor: 3.019

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  [EGFR and gefitinib (Iressa)].

Authors:  Rintaro Noro; Akihiko Gemma
Journal:  Gan To Kagaku Ryoho       Date:  2008-07

10.  [Evidence-based medicine and individualized health care].

Authors:  Jian-Ping Liu
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-06
View more
  1 in total

1.  Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis.

Authors:  Yan-Yan Wei; Wan-Fu Lin; Tian-Hong Zhang; Yun-Xiang Tang; Ji-Jun Wang; Mao-Feng Zhong
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.